During the past decade, Maricopa Medical Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 15 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maricopa Medical Center" #1 sponsor was "Atox Bio Ltd" with 2 trials, followed by "Cumberland Pharmaceuticals" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Instituto Bioclon S.A. de C.V." with 2 trials sponsored and "MedImmune LLC" with 2 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maricopa Medical Center" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "Medical University of South Carolina" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "National Institute of General Medical Sciences (NIGMS)" with 2 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Maricopa Medical Center" are "Burns" (3 trials), "HIV Infections" (3 trials), "COVID-19" (2 trials), "Congestive Heart Failure" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "Maricopa Medical Center" in a lesser frequency.

Most popular intervention types in "Maricopa Medical Center" are "Drug" (30 trials), "Device" (4 trials), "Other" (4 trials), "Procedure" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "NexoBrid" (2 trials), "Rifabutin" (2 trials), "Saline" (2 trials) and "A Lean Implementation Strategy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maricopa Medical Center" are 43 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Maricopa Medical Center". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Maricopa Medical Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Maricopa Medical Center, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".